About the Startup – Vekaria Healthcare LLP


Any vision of the future requires an appreciation of the past.

Vekaria Healthcare LLP was founded by Mr. Yogendra Vekaria, Founder & Managing Director in January 2016, with the vision of entering only in strategic & unique segments of the healthcare sector with prevention & cure, improving quality of care – in mind. Mr. Yogendra Vekaria is of 24 years age – young entrepreneur, He’s done schooling at st. Xavier’s High School, Jamnagar, having done Mechanical Engineering (Diploma & B.Tech, then thought to drop out…) and then also studied Global/Public Health Programme from Harvard T. H. Chan School of Public Health – Harvard University, Boston. (And is also planning to do an MBA programme but highly believes in self-study.) always strives to keep learning. He’s been involved and interested in business since his early childhood, not specific to a sector and has been in various projects related to science & engineering since early childhood & schooling e.g. making a remote-controlled hovercraft from waste/scrapped items in just a day, designing a car for the future solving parking space problems – which’d be converted into a sedan & a hatchback with a single mechanical system within the car, designing & sketching/rendering machines and much more.

Being a young entrepreneur working in the healthcare start-up, with the government, medical field/fraternity, he’s passed through a lot of struggles; also because of his young age. Due to certain people’s limitations of mental ability for acceptance and poor mindset (shallow thinking) that even such a young person can achieve and come up with revolutionary, big research ideas & projects and talk to authorities with well-planned detailed project proposals and can also answer difficult questions, propose & talk about big public policy changes, modifications, up-gradations. Point out flaws in it with solutions too.

The Swearing-in-Ceremony
of the Hon’ble Prime Minister (PM) & Union Council of Ministers

Mr. Yogendra Vekaria has possibly, proudly been one of the youngest to be invited at the Swearing-in-Ceremony of the Hon’ble Prime Minister (PM) Mr. Narendra Modi & Union Council of Ministers, Govt. of India at the Rashtrapati Bhawan, New Delhi on 30th May, 2019.

Mr. Yogendra Vekaria is also working full-time on-board all the group companies (family & other businesses) as a Co-Founder/Founder & Managing Director; and has founded start-ups in the following three sectors: healthcare (Vekaria Healthcare LLP), defence & homeland security (Vekaria Defence Alliance LLP) and renewable energy (Lucas Energy Alliance LLP); and working full-time & serving as the Founder & Managing Director on all the three start-ups.

Mr. Yogendra Vekaria has made a company policy to always enter into something strategic, unique and unconventional with high ethical values; trying as much possible not to enter into conventional & competitive projects/ideas. Even if it’ll be or its highly challenging. Yet to strive, to add value & contribute to the society and should always be addressing a noble cause behind every business or project we enter in/do/start. To always do businesses with a noble cause.


Health is regarded as a human right. We are a company of continuous improvement, constantly striving to be the best. We constantly strive to exceed our expectations.

This led us to explore different verticals. Slowly, steadily we started focusing on this essential business touching the human life.

We deeply studied the field of healthcare, made in-depth research, interacted with leading experts from all over the world and finally decided:

To focus on making the devices user-friendly, inventing new devices & technologies, bringing up new ways & projects to impact the public at large for their betterment. And to make it as cost effective as possible.

With the quote in mind: “Prevention is better than cure.” As, what if there’s no cure? We’ve to focus on prevention and also on finding a cure.

Primarily, one of the flagship start-up projects of Vekaria Healthcare LLP was/is focused on prevention of irreversible, reversible blindness & it’s resultant socio-economic burden to the Society/Govt; proposing big way projects (with a noble cause) to various State Govts; Central Ministries – inducting new bleeding edge medical & innovative tech. in the global public health system & to focus on invention; one of such projects is on-going with the ESIC (Employees’ State Insurance Corporation), Union Labour & Employment Ministry, Govt. of India, inducting a product of Vekaria Healthcare LLP the – Macular Densitometer for prevention of irreversible, reversible blindness at pre-clinical & clinical stages & its resultant socio-economic burden to the Society/Govt; which is a quarter to Indian Rupees (INR/Rs.) 4,000 crores (Rs. 40 billion) project.

Elaborating that, starting from a disease called Macular Degeneration. It is the world’s third largest/leading cause of irreversible blindness as per the WHO. Of which the global prevalence rate is 8.7% according to the WHO. Hence, it’s also listed in the priority eye diseases list by the WHO. Having a huge socio-economic burden on the society & the governments – globally.

So, as we knew – about a medical device called the Macular Densitometer and the entire research team. The Macular Densitometer is the world’s first & the only Gold Standard pre-clinical, clinical stage psycho-physical subjective (test) screening device which can measure/detect the Macular Pigment Optical Density (MPOD), (at pre-clinical, clinical stages). Which means, years before the actual pathology (Macular Degeneration, Diabetic Retinopathy or other diseases…) starts, we can do a simple eye-test. Then, if the MPOD levels are found low. Through prescription, following consumption of simple supplements i.e. a combination of Lutein, Zeaxanthin, Meso-zeaxanthin, vitamins & minerals; we’d increase the density & prevent the irreversibly, reversibly blinding diseases (resulting into prevention of the huge socio-economic burden, saving eyesight and certain cognitive function related neural disorders, which is not the primary target of ours…), also retard the progression at a clinical stage and/or also improve the vision/visual acuity of the subject/patient drastically. The Macular Densitometer was invented (research version & various other versions with clinical improvement including a clinical version; device was also patented) 20 years back by Prof. Billy R. Wooten, Macular Metrics II, LLC, USA.

Hence, we saw immense value & potential in the device. The device is being used for research & clinical practices in more than 200 globally renowned research institutes including the Harvard Medical, The US Department of Defense, Schepens Eye Institute, USA; Sankara Nethralaya, Chennai, India and many more… And many other ophthalmic clinics, as well. Yet, due to the conflict of interest, which is “why’d someone want to prevent an irreversibly blinding disease if they’re making millions & billions out of it?” If a patient gets the disease (Macular Degeneration) he/she is prescribed by the doctor for taking intra-vitreal injections treatment – monthly or quarterly, which is a recurring cost but a huge loss to the patient. Hence, the device wasn’t massively into the common clinical practice, also due to the awareness issue. We also have strong published data, 200+ peer reviewed research papers including certain clinical trials’ data & clinical studies.

Hence, we took it as a challenge with a vision. Coming up, with a massive revolutionary, highly ambitious – irreversible, reversible blindness prevention programme – project, never thought of in the world in such a massive scale nor performed.
Vekaria Healthcare LLP is the sole exclusive technology/IP right holder, global promoter, developer and manufacturer of the device the Macular Densitometer. Vekaria Healthcare LLP is innovating the Macular Densitometer further and coming up with a new high-end, improved, technologically advanced version; and working on inventing further more patent-able, ground-breaking devices/technologies. Hence, the Macular Densitometer is now an exclusive product of Vekaria Healthcare LLP.

The vision of Mr. Yogendra Vekaria was/is to induct the Macular Densitometer in the public health system, at a grass-loot level to benefit the public at large by (primarily with high priority) preventing irreversible, reversible blindness & it’s resultant huge socio-economic burden to the society & the government, saving & improving eyesight – visual acuity, preventing & reducing oxidative stress in the eyes, preventing neural disorders (which isn’t the primary priority).

We’ve been already proposing big way projects to various state governments & central ministries in India, and also exploring opportunities in other governments/nations – globally.

We’d once decided not to enter the private sector due to the possible and/or clear conflict of interest, malpractices, greed. Which we’ve seen & been experiencing since long. Hence, we’d not propose our devices for purchase to any private clinics or institutes unless they eagerly want us to and insist. Yet, as we’ll be mass producing the devices, we’ll invest in the devices and collaborate with private diagnostics centres, clinics, institutions for planting our devices there for screening of patients/people and/or also establishing our own exclusive screening centres across the nation & globally in the next phase, sooner or later.

A lot of private clinics, institutions and governments have shown keen interest (proactively) and are willing to collaborate with us in many more ways.


We’re committed to push the science & technology a step beyond where it is today in the field of healthcare!

While primarily focusing on one aspect, medical devices to begin with, we found that the use of technologies and its developments are moving faster than ever before. This rapid rate of change, creates a world filled with exciting new opportunities. That led us to work more to move the essential technologies forward.

Complex medical technology is rapidly being introduced in healthcare, aimed at imparting diagnosis & treatment. We give more emphasis on preventive & curative healthcare, early diagnosis, reduction in patient discomfort and in improving quality of care. One of our main priorities also is prevention of huge socio-economic burden/impact to the society.

This vast field of healthcare and medicine: tele-medicine, precision medicine, 3D printing, AI, robotics, pharmaceuticals, pharmacogenomics, optics, optometry, genetics, genomics, biotechnology, biochemistry, molecular biology, microbiology, virology, pathology, regenerative medicine, CRISPR and much more is now there in a well organised manner at a different level of evolution in our enterprise. Research & product development, technology transfers, clinical trials, clinical studies… and much more is going on… to help the humanity to minimize or possibly avoid the sufferings due to any kind of ailment.